"B细胞恶性瘤中的单细胞:它们在疾病进展和治疗抵抗中的作用"
Katsiaryna Marhelava1, Justyna Jakubowska2, Agata Pastorczak3
1Department of Immunology, Mossakowski Medical Research Institute, Polish Academy of Sciences, 5 Pawinskiego Str, Warsaw, 02-106, Poland. kmarhelava@imdik.pan.pl.
Current oncology reports
|November 11, 2025
概括
单细胞及其衍生细胞通过驱动治疗耐药性来恶化B细胞恶性瘤. 针对这些抑制细胞显示出改善治疗结果和开发新的免疫疗法的希望.
科学领域:
- 血液学 血液学 血液学
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
背景情况:
- 包括白血病和淋巴瘤在内的B细胞恶性瘤,由于治疗耐药性,存在挑战.
- 瘤微环境显著影响治疗结果和耐药性.
- 单细胞和单细胞衍生细胞是瘤微环境的关键组成部分.
研究的目的:
- 审查单细胞和单细胞衍生细胞在B细胞恶性瘤中的作用.
- 评估针对这些细胞群的治疗策略.
主要方法:
- 关于单细胞和B细胞恶性瘤的最新研究的文献综述.
- 对单细胞衍生细胞对抗瘤免疫力和治疗疗效的影响的分析.
- 对针对这些细胞的新兴治疗策略的评估.
主要成果:
- 单细胞和单细胞衍生细胞与B细胞恶性瘤的不良预后和治疗抵抗有关.
- 这些细胞抑制抗瘤免疫力,促进恶性细胞的存活,并降低治疗的有效性.
- 削弱或重新编程这些群体可以恢复免疫功能并提高治疗效率.
结论:
- 向抑制性单细胞衍生的群体是克服B细胞恶性瘤治疗耐药性的有希望的策略.
- 调节这些细胞可能会减少复发并改善治疗反应,为新型免疫疗法铺平道路.
- 需要进一步的研究来定义特定的疾病相关的亚群,以实现有效的临床转化.
相关概念视频
B Cell Activation and Differentiation
15.9K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
15.9K
Differentiation of Common Myeloid Progenitor Cells
3.9K
Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
3.9K
Disorders of Leukocytes
1.8K
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
1.8K
Cells of the Adaptive Immune Response
8.4K
The T and B lymphocytes of the adaptive immune system develop from common lymphoid progenitor cells in the bone marrow. These progenitors give rise to precursors that eventually develop into both T and B lymphocytes. As these precursors mature, they gain the ability to detect and respond to foreign antigens in the body, a process known as immunocompetence. Additionally, these precursors acquire self-tolerance, a process that ensures they do not react to self-antigens. This intricate system...
8.4K


